926
|
Huo J, Yang G, Zhang Y, Li F. A new strategy for identification of currant (Ribes nigrum L.) cultivars using RAPD markers. GENETICS AND MOLECULAR RESEARCH 2013; 12:2056-67. [PMID: 23913385 DOI: 10.4238/2013.june.21.1] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
We developed a new approach using RAPD fingerprints to distinguish 37 currant cultivars from northeastern China based on optimization of RAPD by choosing 11 nucleotide primers and strict screening PCR annealing temperature. We found that the manual cultivar identification diagram (MCID) approach clearly developed fingerprints from 8 different primers that were useful for cultivar identification; a cultivar identification diagram (CID) was readily constructed. This CID allows efficient currant cultivar identification, providing information to separate all the currant cultivars from each other, based on the detail polymorphic bands from the corresponding primers, which were marked in the correct positions on the currant CID. According to the CID, 10 currant cultivars in 5 groups were randomly selected for the referable and workable identification of this strategy. The results proved the workability and efficiency of the MCID method, facilitating the identification of fruit cultivars with DNA markers. This MCID approach will be useful for early identification of seedlings in the nursery industry and protection of cultivar rights.
Collapse
|
927
|
Ablikim M, Achasov MN, Ai XC, Albayrak O, Ambrose DJ, An FF, An Q, Bai JZ, Baldini Ferroli R, Ban Y, Becker J, Bennett JV, Bertani M, Bian JM, Boger E, Bondarenko O, Boyko I, Briere RA, Bytev V, Cai H, Cai X, Cakir O, Calcaterra A, Cao GF, Cetin SA, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen X, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, Ding WM, Ding Y, Dong LY, Dong MY, Du SX, Fang J, Fang SS, Fava L, Feng CQ, Friedel P, Fu CD, Fu JL, Fuks O, Gao Q, Gao Y, Geng C, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo T, Guo YP, Han YL, Harris FA, He KL, He M, He ZY, Held T, Heng YK, Hou ZL, Hu C, Hu HM, Hu JF, Hu T, Huang GM, Huang GS, Huang JS, Huang L, Huang XT, Huang Y, Huang YP, Hussain T, Ji CS, Ji Q, Ji QP, Ji XB, Ji XL, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kalantar-Nayestanaki N, Kavatsyuk M, Kopf B, Kornicer M, Kühn W, Lai W, Lange JS, Lara M, Larin P, Leyhe M, Li CH, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li K, Li L, Li QJ, Li SL, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Lin D, Liu BJ, Liu CL, Liu CX, Liu FH, Liu F, Liu F, Liu H, Liu HB, Liu HH, Liu HM, Liu HW, Liu JP, Liu K, Liu KY, Liu K, Liu PL, Liu Q, Liu SB, Liu X, Liu YB, Liu ZA, Liu Z, Liu Z, Loehner H, Lou XC, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Ma CL, Ma FC, Ma HL, Ma QM, Ma S, Ma T, Ma XY, Maas FE, Maggiora M, Malik QA, Mao YJ, Mao ZP, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Mo YJ, Moeini H, Morales Morales C, Moriya K, Muchnoi NY, Muramatsu H, Nefedov Y, Nicholson C, Nikolaev IB, Ning Z, Olsen SL, Ouyang Q, Pacetti S, Park JW, Pelizaeus M, Peng HP, Peters K, Ping JL, Ping RG, Poling R, Prencipe E, Qi M, Qian S, Qiao CF, Qin LQ, Qin XS, Qin Y, Qin ZH, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schaefer BD, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song WM, Song XY, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tapan I, Thorndike EH, Toth D, Ullrich M, Uman I, Varner GS, Wang BQ, Wang D, Wang DY, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang QJ, Wang SG, Wang XF, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Wei JB, Weidenkaff P, Wen QG, Wen SP, Werner M, Wiedner U, Wu LH, Wu N, Wu SX, Wu W, Wu Z, Xia LG, Xia YX, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu GM, Xu QJ, Xu QN, Xu XP, Xu ZR, Xue F, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yu BX, Yu CX, Yu HW, Yu JS, Yu SP, Yuan CZ, Yuan Y, Zafar AA, Zallo A, Zang SL, Zeng Y, Zhang BX, Zhang BY, Zhang C, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang R, Zhang SH, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZP, Zhang ZY, Zhang Z, Zhao G, Zhao HS, Zhao JW, Zhao KX, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zhong B, Zhou L, Zhou X, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu YC, Zhu YM, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH. Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26 GeV. PHYSICAL REVIEW LETTERS 2013; 110:252001. [PMID: 23829729 DOI: 10.1103/physrevlett.110.252001] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2013] [Indexed: 06/02/2023]
Abstract
We study the process ee+ e- → π+ π- J/ψ at a center-of-mass energy of 4.260 GeV using a 525 pb(-1) data sample collected with the BESIII detector operating at the Beijing Electron Positron Collider. The Born cross section is measured to be (62.9±1.9±3.7) pb, consistent with the production of the Y(4260). We observe a structure at around 3.9 GeV/c2 in the π(±)J/ψ mass spectrum, which we refer to as the Z(c)(3900). If interpreted as a new particle, it is unusual in that it carries an electric charge and couples to charmonium. A fit to the π(±)J/ψ invariant mass spectrum, neglecting interference, results in a mass of (3899.0±3.6±4.9) MeV/c2 and a width of (46±10±20) MeV. Its production ratio is measured to be R = (σ(e+ e- → π(±)Z(c)(3900)(∓) → π+ π- J/ψ)/σ(e+ e- → π+ π- J/ψ)) = (21.5±3.3±7.5)%. In all measurements the first errors are statistical and the second are systematic.
Collapse
|
928
|
Han X, Li F. Percutaneous ethanol injection for the treatment of axillary osmidrosis. Clin Exp Dermatol 2013; 38:484-8. [PMID: 23777489 DOI: 10.1111/ced.12020] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/08/2012] [Indexed: 12/16/2022]
|
929
|
Du H, Wang C, Wang X, Ma M, Li F. The effects of dietary α-linolenic acid on growth performance, meat quality, fatty acid composition and liver relative enzyme mRNA expression of growing meat rabbits. JOURNAL OF ANIMAL AND FEED SCIENCES 2013. [DOI: 10.22358/jafs/66002/2013] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
930
|
Ma L, Zhu Y, Sun H, Li F, Shao Y, Zhang S. A Lesson from a Rare Cause of Pulmonary Embolism. Respir Care 2013; 58:e149-52. [DOI: 10.4187/respcare.02362] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
931
|
Wang HW, Yang W, Lu JY, Tian G, Li F, Wang XH, Kang JR, Yang Y. Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice. Clin Exp Immunol 2013; 170:156-66. [PMID: 23039886 DOI: 10.1111/j.1365-2249.2012.04641.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Depletion and dysfunction of dendritic cells in the lung can induce local immunoparalysis, which often leads to multiple organ dysfunction syndrome (MODS)-associated mortality. A therapeutic strategy that reverses this immunoparalysis is required. In the present study, we examined the effects of in vivo Fms-like tyrosine kinase 3 ligand (Flt3L) treatment on zymosan (zym)-induced secondary lung injury and dendritic cell (DC) immunoparalysis. BALBc mice were divided randomly into four groups (20/group): (1) sham [intraperitoneal (i.p.) saline] + vehicle [subcutaneous (s.c.) 0·01% mouse serum albumin]; (2) sham + Flt3L (s.c.); (3) zym (i.p.) + vehicle; and (4) zym + Flt3L. Injections were for 9 consecutive days; 12 days later we examined: survival rate (monitored for 12 days); lung tissue histopathology (haematoxylin and eosin staining); plasma indices of lung function (pH, PaO(2) , PaCO(2) , HCO(3) (-) ); DC subsets in lung tissue; and lung DCs production of interleukin (IL)-12p70 and IL-10. Zym administration resulted in increased mortality associated with significant lung histopathological changes and abnormal blood gas indices; however, these pathological changes were ameliorated by Flt3L treatment. Zym injections also resulted in significant reductions in DC subsets recovered from lungs [CD11c(+) major histocompatibility complex (MHC)-II/I-A(d+) , CD11c(+) CD11b(+) and CD11c(+) B220(+) ]. Importantly, in-vivo Flt3L treatment reversed these trends for DC immunoparalysis by increasing the percentages of recovered DC subsets concomitant with increased DC production of IL-12 p70 and decreased IL-10 production. These results suggest that Flt3L may have therapeutic potential for reversing DC immunoparalysis and ameliorating lung injury secondary to MODS.
Collapse
|
932
|
Li P, Fang YJ, Li F, Ou QJ, Chen G, Ma G. ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy. Br J Cancer 2013; 108:1238-44. [PMID: 23481186 PMCID: PMC3619275 DOI: 10.1038/bjc.2013.83] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Background: Excision repair cross-complementation group 1 (ERCC1) expression status has been identified as a candidate marker for predicting efficacy of oxaliplatin (OX) treatment for metastatic colorectal cancer (CRC) in several trials. Also, an association between expression of mismatch repair (MMR) genes and favourable postoperative survival in stage II CRC receiving 5-FU chemotherapy has been identified. It is unknown if the expression of ERCC1 protein and MMR status are associated with survival of stage III colon cancer receiving OX-based chemotherapy. Methods: Immunohistochemistry (IHC) analysis of the expression of MMR and ERCC1 was performed on tumour tissue of 255 patients with stage III colon cancer. In all, 95 patients received fluoropyrimidine-based chemotherapy and 160 patients received OX-based chemotherapy. A predictive model for 5-year disease-free survival (DFS) and overall survival (OS) was constructed using Kaplan–Meier analysis, logistic and Cox regression. Results: Patients who were treated with OX-based therapy with positive ERCC1 tumours had lower 5-year DFS (54%) and OS (60%) than those with negative ERCC1 tumours (72% and 78%, respectively; DFS HR: 1.98, 95% confidence interval (CI): 1.19–3.31, P=0.009; OS HR: 2.44, 95% CI: 1.37–4.34, P=0.02). Excision repair cross-complementation group 1 status did not impact DFS or OS in fluorouracil group (DFS HR: 1.16, 95% CI: 0.63–2.14, P=0.62; OS HR: 1.16, 95% CI: 0.63–2.14, P=0.63), whereas MMR status had no impact on DFS or OS in either group. Conclusion: Excision repair cross-complementation group 1 status is highly predictive of which patients will benefit from the addition of OX to 5-FU for stage III colon cancer. Mismatch repair status had no predictive value in this setting.
Collapse
|
933
|
Ablikim M, Achasov MN, Albayrak O, Ambrose DJ, An FF, An Q, Bai JZ, Ban Y, Becker J, Bennett JV, Bertani M, Bian JM, Boger E, Bondarenko O, Boyko I, Briere RA, Bytev V, Cai X, Cakir O, Calcaterra A, Cao GF, Cetin SA, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen X, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, Ding WM, Ding Y, Dong LY, Dong MY, Du SX, Fang J, Fang SS, Fava L, Feng CQ, Ferroli RB, Friedel P, Fu CD, Gao Y, Geng C, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo T, Guo YP, Han YL, Harris FA, He KL, He M, He ZY, Held T, Heng YK, Hou ZL, Hu C, Hu HM, Hu JF, Hu T, Huang GM, Huang GS, Huang JS, Huang L, Huang XT, Huang Y, Huang YP, Hussain T, Ji CS, Ji Q, Ji QP, Ji XB, Ji XL, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kalantar-Nayestanaki N, Kavatsyuk M, Kopf B, Kornicer M, Kuehn W, Lai W, Lange JS, Leyhe M, Li CH, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li K, Li L, Li QJ, Li SL, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Lin D, Liu BJ, Liu CL, Liu CX, Liu FH, Liu F, Liu F, Liu H, Liu HB, Liu HH, Liu HM, Liu HW, Liu JP, Liu K, Liu KY, Liu K, Liu PL, Liu Q, Liu SB, Liu X, Liu YB, Liu ZA, Liu Z, Liu Z, Loehner H, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Ma CL, Ma FC, Ma HL, Ma QM, Ma S, Ma T, Ma XY, Maas FE, Maggiora M, Malik QA, Mao YJ, Mao ZP, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Morales Morales C, Muchnoi NY, Muramatsu H, Nefedov Y, Nicholson C, Nikolaev IB, Ning Z, Olsen SL, Ouyang Q, Pacetti S, Park JW, Pelizaeus M, Peng HP, Peters K, Ping JL, Ping RG, Poling R, Prencipe E, Qi M, Qian S, Qiao CF, Qin LQ, Qin XS, Qin Y, Qin ZH, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schaefer BD, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song XY, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tapan I, Thorndike EH, Toth D, Ullrich M, Varner GS, Wang BQ, Wang D, Wang DY, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang QJ, Wang SG, Wang XF, Wang XL, Wang YF, Wang Z, Wang ZG, Wang ZY, Wei DH, Wei JB, Weidenkaff P, Wen QG, Wen SP, Werner M, Wiedner U, Wu LH, Wu N, Wu SX, Wu W, Wu Z, Xia LG, Xia YX, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu GM, Xu QJ, Xu QN, Xu XP, Xu ZR, Xue F, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yu BX, Yu CX, Yu HW, Yu JS, Yu SP, Yuan CZ, Yuan Y, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang C, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang R, Zhang SH, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZP, Zhang ZY, Zhang Z, Zhao G, Zhao HS, Zhao JW, Zhao KX, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao QZ, Zhao SJ, Zhao TC, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zhong B, Zhong Z, Zhou L, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu YC, Zhu YM, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH. Measurements of the branching fractions forJ/ψandψ′→ΛΛ¯π0andΛΛ¯η. Int J Clin Exp Med 2013. [DOI: 10.1103/physrevd.87.052007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
934
|
Li Y, Li F, Cheng X, Yang Y. Experimental investigation on the temperature distribution in the cavity pool of ex-vessel cooling system. ANN NUCL ENERGY 2013. [DOI: 10.1016/j.anucene.2012.08.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
935
|
Li F, Zhang L, Wu X, Li C, Yang X, Dong Y, Lemme A, Han J, Yao J. Effects of metabolizable energy and balanced protein on egg production, quality, and components of Lohmann Brown laying hens. J APPL POULTRY RES 2013. [DOI: 10.3382/japr.2012-00568] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
936
|
|
937
|
Wei H, Li F, Fu P, Liu X. Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2013; 17:436-446. [PMID: 23467940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
BACKGROUND Hypoxia plays a crucial role in the development of solid tumors. Hypoxia-inducible factor-1alpha (HIF-1alpha) is essential for this process, and has been suggested to be a target for cancer therapy. New therapeutic approaches for pancreatic cancer are needed owing to the extremely poor prognosis, in large part as a consequence of high rates of metastasis. The mechanism remains to be explored. AIM To illustrate the role of hypoxia-inducible factor-1alpha in pancreatic cancer metastasis and the value of the molecule as a target for pancreatic cancer therapy. MATERIALS AND METHODS To address this shortcoming, we used both in vitro and in vivo approaches to evaluate the overall effects of HIF-1alpha on pancreatic cancer. We used a plasmid encoding small interfering RNAs (SiRNAs) to silence HIF-1alpha expression in the Panc-1 pancreatic cancer cell line, and used a series of assays to detect changes in gene expression at the protein and mRNA levels, cell proliferation, cell apoptosis, and the abilities of cells to migrate under both hypoxia and normoxia conditions. RESULTS Both in vitro and in vivo analysis suggested that hypoxia significantly promotes cell proliferation and migration, resulting in metastasis. Pancreatic cancer cells in which HIF-1alpha expression was inhibited were less invasive, with reduced resistance to hypoxia, impaired migration, and reduced capacity to cause metastasis. CONCLUSIONS HIF-1alpha may be a dominant factor driving the metastatic progression of pancreatic cancer and can be a potent therapeutic target for the disease.
Collapse
|
938
|
Cao J, Wang Z, Dong Y, Zhang Z, Li J, Li F, Chen Y. Effect of combinations of monochromatic lights on growth and productive performance of broilers. Poult Sci 2013; 91:3013-8. [PMID: 23155007 DOI: 10.3382/ps.2012-02413] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Our previous study suggested that green light promotes broiler growth during the early stage [posthatching day (P) 0 to P26], and blue light enhances growth during the later stage (P27 to P49). The purpose of this study was to improve broiler growth and productive performance by using a combination of monochromatic lights at critical points between the early and later stages of growth. A total of 512 male Arbor Acres broilers on P0 were reared under white light (W), red light (R), green light (G), and blue light (B) by using light-emitting diode lamps at 15 ± 0.2 lx from P0 to P26 (16 replicate pens/group, 8 birds/pen), and then switching to another color of light until P49 (4 replicate pens/group, 8 birds/pen). As compared with single monochromatic lights, broilers reared in environments under combinations of monochromatic lights, W→G, R→B, G→B, and B→G, attained heavier BW than those reared in environments under W→W (3.18 to 12.00%), R→R (1.96 to 18.14%), G→G (0.85 to 5.08%), and B→B (0.39 to 4.70%), respectively. In addition, feed conversion ratios in the W→B, R→B, and G→B combinations were lower than feed conversion ratios for W→W (15.86%, P < 0.05), R→R (18.41%, P < 0.05), and G→G (3.37%), respectively. Moreover, the eviscerated carcass weight and breast, thigh, and crus muscle weights under G→B were greater by 0.40 to 56.23% than were those for the other light groups except W→B (eviscerated carcass) and B→G (breast muscle). The results suggest that the application of the G→B and B→G exchanges can be used successfully to improve growth and productive performance in broilers.
Collapse
|
939
|
Cao Z, Li F, Okonkwo CM, van den Boom HPA, Chen M, Yang B, Zou S, Tangdiongga E, Chen L, Koonen AMJ. Synchronized signaling delivery for broadband 60 GHz in-building optical wireless network based on digital frequency division multiplexing and digital Nyquist shaping. OPTICS EXPRESS 2013; 21:270-275. [PMID: 23388920 DOI: 10.1364/oe.21.000270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
A simple and low-cost synchronized signaling delivery scheme has been proposed for a 60 GHz in-building optical wireless network with 12.7Gbps throughput based on digital frequency division multiplexing and digital Nyquist shaping.
Collapse
|
940
|
Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, Zhao R, Huang H, Wang X, Qiao Y, Li F, Han D, Wang L, Zhang G, Gao X. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene 2013; 33:378-86. [DOI: 10.1038/onc.2012.575] [Citation(s) in RCA: 160] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2012] [Revised: 10/09/2012] [Accepted: 10/23/2012] [Indexed: 12/15/2022]
|
941
|
Ablikim M, Achasov MN, Ambrose DJ, An FF, An Q, An ZH, Bai JZ, Ban Y, Becker J, Berger N, Bertani M, Bian JM, Boger E, Bondarenko O, Boyko I, Briere RA, Bytev V, Cai X, Calcaterra A, Cao GF, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen Y, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, Ding WM, Ding Y, Dong LY, Dong MY, Du SX, Fang J, Fang SS, Fava L, Feldbauer F, Feng CQ, Ferroli RB, Fu CD, Fu JL, Gao Y, Geng C, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo YP, Han YL, Hao XQ, Harris FA, He KL, He M, He ZY, Held T, Heng YK, Hou ZL, Hu HM, Hu JF, Hu T, Huang B, Huang GM, Huang JS, Huang XT, Huang YP, Hussain T, Ji CS, Ji Q, Ji XB, Ji XL, Jia LK, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kalantar-Nayestanaki N, Kavatsyuk M, Kühn W, Lai W, Lange JS, Leung JKC, Li CH, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li K, Li L, Li NB, Li QJ, Li SL, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Liu BJ, Liu BJ, Liu CL, Liu CX, Liu CY, Liu FH, Liu F, Liu F, Liu H, Liu HB, Liu HH, Liu HM, Liu HW, Liu JP, Liu KY, Liu K, Liu K, Liu PL, Liu SB, Liu X, Liu XH, Liu Y, Liu YB, Liu ZA, Liu Z, Liu Z, Loehner H, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Ma CL, Ma FC, Ma HL, Ma QM, Ma S, Ma T, Ma XY, Ma Y, Maas FE, Maggiora M, Malik QA, Mao H, Mao YJ, Mao ZP, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Morales Morales C, Motzko C, Muchnoi NY, Nefedov Y, Nicholson C, Nikolaev IB, Ning Z, Olsen SL, Ouyang Q, Pacetti S, Park JW, Pelizaeus M, Peters K, Ping JL, Ping RG, Poling R, Prencipe E, Pun CSJ, Qi M, Qian S, Qiao CF, Qin XS, Qin Y, Qin ZH, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schulze J, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song XY, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun XD, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Thorndike EH, Tian HL, Toth D, Ullrich M, Varner GS, Wang B, Wang BQ, Wang JX, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang Q, Wang QJ, Wang SG, Wang XF, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Weidenkaff P, Wen QG, Wen SP, Werner M, Wiedner U, Wu LH, Wu N, Wu SX, Wu W, Wu Z, Xia LG, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu GM, Xu H, Xu QJ, Xu XP, Xu Y, Xu ZR, Xue F, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang T, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yu BX, Yu CX, Yu JS, Yu SP, Yuan CZ, Yuan WL, Yuan Y, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang J, Zhang JG, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang SH, Zhang TR, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang YS, Zhang ZP, Zhang ZY, Zhao G, Zhao HS, Zhao JW, Zhao KX, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zheng ZP, Zhong B, Zhong J, Zhou L, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu XW, Zhu YM, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH, Zuo JX. Observation of two new N* resonances in the decay ψ(3686)→ppπ0. PHYSICAL REVIEW LETTERS 2013; 110:022001. [PMID: 23383891 DOI: 10.1103/physrevlett.110.022001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/25/2012] [Indexed: 06/01/2023]
Abstract
Based on 106×10(6)ψ(3686) events collected with the BESIII detector at the BEPCII facility, a partial wave analysis of ψ(3686)→ppπ0 is performed. The branching fraction of this channel has been determined to be B(ψ(3686)→ppπ0)=(1.65±0.03±0.15)×10(-4). In this decay, 7 N* intermediate resonances are observed. Among these, two new resonances, N(2300) and N(2570) are significant, one 1/2+ resonance with a mass of 2300(-30-0)(+40+109) MeV/c2 and width of 340(-30-58)(+30+110) MeV/c2, and one 5/2- resonance with a mass of 2570(-10-10)(+19+34) MeV/c2 and width of 250(-24-21)(+14+69) MeV/c2. For the remaining 5 N* intermediate resonances [N(1440), N(1520), N(1535), N(1650) and N(1720)], the analysis yields mass and width values that are consistent with those from established resonances.
Collapse
|
942
|
Wang L, Niu Z, Zhang L, Liu X, Wang X, Li F, Wang Y. Clinicopathological significance of mesothelin expression in invasive breast cancer. J Int Med Res 2013; 40:909-16. [PMID: 22906263 DOI: 10.1177/147323001204000309] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVES This study evaluated the expression profile of the mesothelin (MSLN) gene and its prognostic significance in breast cancer. METHODS To evaluate the diagnostic and prognostic significance of mesothelin, immunohistochemistry was used to assess the level of mesothelin protein in surgically resected, formalin-fixed, paraffin-embedded invasive breast carcinoma specimens. Associations between mesothelin and other biomarkers, including oestrogen receptor (OR), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2/neu), were also evaluated. RESULTS A total of 182 breast carcinoma specimens were included. Mesothelin protein was present in the membrane of malignant cells. There was correlation between the presence of mesothelin in tumour cells and tumour infiltration of the lymph node. There was no correlation between the presence of mesothelin and HER2/neu protein, OR and PR in tumour cells. Mesothelin levels were significantly associated with decreased overall survival. CONCLUSIONS Lymph node status, tumour size, HER2/neu and mesothelin protein levels in breast cancer cells were independent prognostic factors. Mesothelin could be useful as a prognostic marker of overall survival in invasive breast cancer.
Collapse
|
943
|
Li J, Li J, Li F, Li F, Wang H, Wang H, Wang X, Wang X, Jiang Y, Jiang Y, Li D, Li D. Wortmannin reduces metastasis and angiogenesis of human breast cancer cells via nuclear factor-κB-dependent matrix metalloproteinase-9 and interleukin-8 pathways. J Int Med Res 2013; 40:867-76. [PMID: 22906259 DOI: 10.1177/147323001204000305] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
OBJECTIVE To investigate whether inhibition of Akt phosphorylation by the phosphatidylinositol 3-kinase (PI3K) inhibitor, wortmannin, reduces metastasis and angiogenesis in a human breast cancer cell line via nuclear factor (NF)-κB-dependent matrix metalloproteinase (MMP)-9 and interleukin (IL)-8 pathways. METHODS MDA-MB-231 cells were treated with wortmannin 0-200 nM for 4 h. Restoration of Akt activity was evaluated by transfection of cells with constitutively active myristoylated Akt (myr-Akt). NF-κB, MMP-9 and IL-8 proteins were detected by electrophoretic mobility shift assay, Western blot or enzyme-linked immunosorbent assay. The chicken embryo chorio-allantoic membrane assay, cell motility and migration assays were used to evaluate angiogenesis and invasion in vitro. A mouse pseudo metastatic breast cancer model was used to assess the effects of wortmannin on metastasis and angiogenesis in vivo. RESULTS Wortmannin inhibited the phosphorylation of Akt, upregulation of NF-κB, MMP-9, IL-8, and in vitro cell invasion and angiogenesis, in a dose-dependent manner. Transfection of myr-Akt reversed the cellular and biochemical effects of wortmannin in vitro. Wortmannin also significantly inhibited tumour metastasis and angiogenesis in vivo. CONCLUSION The findings of the present study suggest that wortmannin inhibits metastasis and angiogenesis in breast cancer cells via PI3K/Akt/NF-κB-mediated MMP-9 and IL-8 signalling pathways.
Collapse
|
944
|
Su H, Xu Y, Jiang K, Li F, Zhang X, Fang Y. 2833 – A six year follow-up study of cognitive change in first onset depressive patients. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)77417-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
945
|
Liu W, Li F, He Z, Ai R, Ma H. Molecular analysis of the SMN gene mutations in spinal muscular atrophy patients in China. GENETICS AND MOLECULAR RESEARCH 2013; 12:3598-604. [DOI: 10.4238/2013.september.13.4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
946
|
Dong Y, Li F, Pei X, Wang F, Yuan Q, Wu H, Jia S, Peng Y. Genome-wide multilocus analysis of intraspecific differentiation in Oryza rufipogon Griff. from China and the influence of introgression from O. sativa L. GENETICS AND MOLECULAR RESEARCH 2013; 12:6103-19. [DOI: 10.4238/2013.december.2.8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
947
|
Hu JM, Li L, Chen YZ, Pang LJ, Yang L, Liu CX, Zhao J, Chang B, Zou H, Qi Y, Liang WH, Li F. Human papillomavirus type 16 infection may be involved in esophageal squamous cell carcinoma carcinogenesis in Chinese Kazakh patients. Dis Esophagus 2013; 26:703-7. [PMID: 23607265 DOI: 10.1111/dote.12009] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The aim of this study was to investigate human papillomavirus type 16 (HPV16) prevalence in esophageal squamous cell carcinoma (ESCC) in Xinjiang Kazakh patients and its role in ESCC carcinogenesis. One hundred and fifty cases of ESCC and 150 cases of corresponding normal esophageal mucosa (CNGM) samples were collected from north Xinjiang where the Kazakh ethnic group has lived since ancient times. HPV16 infection in ESCC and CNGM was detected by genotype-specific polymerase chain reaction. HPV16 DNA was detected in 55 of 150 ESCC samples (36.7%) and 24 of 150 corresponding normal esophageal mucosa samples (16%) with significant differences (P < 0.001, odds ratio = 3.039, 95% confidence interval: 1.756-5.260). No statistically significant correlations were found between HPV16 infection and the age or gender of patients, tumor site, tumor cell differentiation, or lymph node metastasis (P > 0.05). HPV16 infection is common in cases of ESCC in the Kazakh ethnic group in Xinjiang and may be involved in ESCC carcinogenesis.
Collapse
|
948
|
Zeng H, Tao Y, Chen X, Zeng P, Wang B, Wei R, Yao C, Xie Y, Li F, Tang Y, Cui Y, Sun G. Primary immunodeficiency in south China: clinical features and a genetic subanalysis of 138 children. J Investig Allergol Clin Immunol 2013; 23:302-308. [PMID: 24260974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023] Open
Abstract
OBJECTIVES We analyzed the clinical features of 138 patients with primary immunodeficiency (PID) and performed genetic testing on a subset of patients in order to complete gaps in research on PID in South China and thus improve pediatricians' ability to recognize and diagnose PID. METHODS We performed a retrospective analysis based on the medical records of PID patients hospitalized in our institution between May 1999 and June 2012. Gene sequencing was performed in 59 cases. RESULTS Children with PID usually present with fever and repeated infections that generally affect the respiratory and digestive tracts. Growth retardation is observed in some cases. Of the 138 patients, 113 were boys, median age at onset was 5 months (range, 0-119 months), and age at diagnosis was 10 months (2-159 months). A family history of repeated infection or death of family members in infancy because of recurrent infections was recorded in 20 cases (14.49%). Antibody defects were detected in 48 cases (34.78%), combined immunodeficiency disease in 45 cases (32.61%), and other well-defined immunodeficiency syndromes in 45 cases (32.61%). Of the 59 patients from the genetic subanalysis, 24 (15.94%) had a genetic mutation (x-linked agammaglobulinemia, 8 cases; severe combined immunodeficiency, 8 cases; hyperimmunoglobulin M syndrome, 3 cases; hyperimmunoglobulin E syndrome, 3 cases; chronic granulomatous disease, 2 cases). We detected 4 novel mutations. No relevant mutations were found in the remaining 35 cases.After treatment with intravenous immunoglobulin and anti-infectious agents, 16 patients died in hospital, and 5 cases died after discontinuing treatment (mortality, 15.22%). CONCLUSIONS In recent years, the number of patients with PID has risen gradually in South China. Genetic testing can confirm diagnosis. Since PID seriously affects children's quality of life, it is important to diagnose, treat, and intervene early.We hope our clinical and genetic analyses of children with PID can provide diagnostic guidance for clinicians.
Collapse
|
949
|
Liu X, Zhang Z, Hou B, Wang D, Sun T, Li F, Wang H, Han S. Rapid identification of Sporothrix schenckii in biopsy tissue by PCR. J Eur Acad Dermatol Venereol 2012; 27:1491-7. [PMID: 23278977 DOI: 10.1111/jdv.12030] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
BACKGROUND The dimorphic fungus Sporothrix schenckii is the etiological agent of sporotrichosis, an important cutaneous mycosis with a worldwide distribution. At present, it is challenging to rapidly discover and identify Sporothrix schenckii in biopsy tissues nowadays. AIMS To explore new methods for rapid diagnosis of sporotrichosis. MATERIALS AND METHODS We screened specific primers for Sporothrix schenckii using 50 clinical isolates from patients with sporotrichosis. DNA was extracted from the lesions of 30 cases of clinically suspected sporotrichosis using the Graham s method of CTAB and amplified by PCR using the screened specific primers. RESULTS The primer S2-R2 was applicable for the identification of S. schenckii from different geographic areas and clinical types with high specificity and sensitivity. Twenty-five out of the thirty cases (83.3%) amplified using the primer S2-R2 showed positive bands. Further positive bands were observed in 95.6% of cases tested positive by fungal culture. CONCLUSIONS Using the PCR technique and specific primers, we developed a new diagnostic method that can rapidly diagnose sporotrichosis with tissues obtained from clinical biopsies.
Collapse
|
950
|
Zhan M, Li F, Zhu Y, Ma J, Landua J, Wei W, Vadakkan T, Zhang M, Dickinson M, Lewis M, Rosen J, Wong S. Abstract P4-02-08: Quantitative Characterization of 3D Vasculature Spatial Patterns Within Tumor Microenvironment of Breast Cancer Stem Cells. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p4-02-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The sustainment characters of cancer stem cells (CSCs) such as self-renew and differentiation to other tumor cells greatly depend on the tumor microenvironment, which is composed of many components, e.g. vasculature, extracellular matrix, epithelial cells, stromal cells, as well as nutrients and oxygen. As vasculature is an important factor for the CSC and tumor development, the understanding of their spatial patterns is essential for calibrating the CSC-microenvironment interactions in mathematical modeling. In this study, we acquired the vasculature in side tumors and normal breast tissues by using two-photon fluorescence microscopy, which enables 3D in vivo imaging. We developed an advanced vasculature segmentation approach for an objective and accurate quantification of the vasculature in 3D image volumes. The approach integrates supervoxel analysis and the orientation guided hidden Markov random field (ori-HMRF) modeling together to compensate for low quality images, e.g., low signal-to-noise ratio (SNR) and uneven background. By constructing a new feature space that combines the CIELAB color space and the coordinates space, the supervoxel analysis divides an image volume into subregions with local similar intensity and restricted regular shape, boundaries of which can delineate the vasculature boundaries accurately even in low intensity contrast regions. We further designed a set of features for the separation of blood vessel regions from the background. To make use of the context information, i.e. the continuity of vasculature, the ori-HMRF model is used to incorporate the consistency of vasculatures' orientation in order to reduce the false positives and negatives. Experimental results on image volumes from both breast cancer and normal breast tissues show that the proposed method can effectively reconstruct the vasculature structure with the CSC embedded tumor microenvironment.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P4-02-08.
Collapse
|